#JASN
🚨 Late Breaking #1
🌟 Hiddo Heerspink on finerenone in FSGS (FIND-CKD): see albuminuria and proteinuria 🔎
👉 https://journals.lww.com/jasn/pdf/10.1681/asn.0000001333~finerenone-in-patients-with-focal-segmental
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrial
November 15, 2026 at 5:26 PM
New from #NephFaculty Dr Edmonston and Dr Catanese in JASN

Implementation Strategies to Improve CKD Testing and Delivery of Guideline-Directed Medical Therapy: A Scoping Review

https://pubmed.ncbi.nlm.nih.gov/43019564/
November 13, 2026 at 10:09 PM
Oni se itak samo hecajo. (Spet mi je na pamet prletela ona od Jelke: Pa, dobr, kaj teb ni jasn?!)
November 10, 2026 at 10:34 AM
💊 When should we stop medications in #CKD?

As CKD progresses, benefits & harms may shift.

STOP-ACEi challenged assumptions about stopping RAAS inhibitors in advanced CKD.

📑 A #JASN article highlights why randomized discontinuation trials matter.

🔗 journals.lww.com/jasn/pdf/10....
Randomized Treatment Discontinuation Trials in... : Journal of the American Society of Nephrology
Abstract was not provided for this article.
journals.lww.com
November 11, 2026 at 2:13 PM
Pa, dobr, kaj tebi ni jasn!? 😂
November 6, 2026 at 4:48 AM
Jeden Tag ein #JulianTuwim Gedicht, Tag 1730. Heute das Gedicht Noc księżycowa, Mondnacht, von 1912.
November 8, 2026 at 4:21 PM
Pa ka teb ni jasn!
November 4, 2026 at 2:03 AM
Potem bodo pa spet jokali, da jih obtožujemo, da so pijanci - kot gospa Pa-dobr-pa-ka-teb-ni-jasn.
November 3, 2026 at 9:05 PM
The November issue of JASN is now available online! Topics covered include:
- SGLT2i in a Mouse Model of ANCA-Associated Vasculitis
- Pregnancy and CKD Progression in ADPKD
- and more
kidney.pub/JASN-1126
#ASNJASN
November 3, 2026 at 4:04 PM
Ka pa teb ni jasn
November 3, 2026 at 7:38 PM
Trump — Vance odhalil hlavného vinníka republikánskeho neúspechu a Trump mu dôveruje #Trump #Republikánov #RepublikánskejStrany #News
Trump podporuje Vanceho návrh na vinníka republikánskeho porážky
Viceprezident Mike Pence podporuje návrh Mikea Vancea, ktorý identifikuje hlavného vinníka neúspechu republikánskej strany v predvolebných debate. Vance tvrdí, že hlavným problémom bol nedostatok jasn…
news.netasgard.com
November 4, 2026 at 5:06 PM
Journal of the American Society of Nephrology (JASN)
ASN Kidney Translation Series: JASN Late-Breaking Clinical Trials
Journal of the American Society of Nephrology (JASN) · Episode
open.spotify.com
November 1, 2026 at 4:17 AM
Ko bom jaz mel komando (tak kot ovi na tviteri) nad 700 profili za diskreditacijo, bom ob kaki objavi fotke hrane, dal totim profilom komando: Delite mojo podobjavo, da na vzorci dobim bolj jasn odgovor, če je že poročena!
Samo jaz je ne bom diskreditiro 😇
October 31, 2026 at 7:17 AM
🫘 Empagliflozin in ADPKD: A pilot RCT (JASN; n=50) showed good tolerability and an early eGFR dip followed by stabilization, but greater kidney volume increase vs placebo.

🔬 Larger trials needed.

🔗 www.ovid.com/jnls/jasn/fu...
Empagliflozin Therapy in Autosomal Dominant... : Journal of the American Society of Nephrology
Key PointsEmpagliflozin 25 mg once daily for 12 months was safe and well tolerated in adults with autosomal dominant polycystic kidney disease at...
www.ovid.com
October 27, 2026 at 5:02 PM
Another LBCT from today’s #KidneyWk

journals.lww.com/jasn/abstrac... in @asnpublications.bsky.social #JASN

ADPKD has been excluded from flozins trials (concern about cyst growth) - and this pilot trial does show that

VA by @edgarvlermamd.medsky.network
October 24, 2026 at 10:54 PM
Latest ASN Kidney Translation Podcast episode features the 2026 Trainees of the Year: Kidney360 on MRI-based kidney stress testing, CJASN on intratubular cast composition using spatial protein imaging, and JASN on tenascin C–mediated kidney regeneration in axolotls. kidney.pub/KTPOD102226
October 25, 2026 at 6:50 PM
#KidneyWk LBCTs in JASN @asnpublications.bsky.social this time

Upacicalcet in HD - IV formulation reduces PTH

journals.lww.com/jasn/fulltex...

With VA from @edgarvlermamd.medsky.network
October 23, 2026 at 11:21 PM
Journal of the American Society of Nephrology (JASN)
Dialysis Discontinuation Rates in Patients with AKI
Journal of the American Society of Nephrology (JASN) · Episode
open.spotify.com
October 23, 2026 at 9:47 PM
Journal of the American Society of Nephrology (JASN)
ASN Kidney Translation Series: 2026 ASN Journals' Trainees of the Year
Journal of the American Society of Nephrology (JASN) · Episode
open.spotify.com
October 23, 2026 at 9:42 PM
#KidneyWk late breaking studies

vascular access survival trends in JASN @asnpublications.bsky.social

journals.lww.com/jasn/abstrac...

#KidneyWk
October 22, 2026 at 6:36 PM
Checking your browser - reCAPTCHA
pubmed.ncbi.nlm.nih.gov
October 22, 2026 at 11:04 PM
Join the Best of ASN Journals session at #KidneyWk 2026. Explore influential research from JASN, CJASN, and Kidney360, including the latest advances in cardiovascular-kidney-metabolic health, glomerulonephritis, nutrition, and polycystic kidney disease.
kidney.pub/bestofses...
October 23, 2026 at 4:13 PM
Trends in Mortality of Patients with Central Venous Catheters (CVC) vs Arteriovenous (AV) Accesses for Hemodialysis ca. 2026 from @asnpublications.bsky.social
#Nephpearls #VascularAccessPearls #KidneyWk #NephSky

👉 journals.lww.com/jasn/fulltex...
October 22, 2026 at 11:30 PM
Congratulations to the 2026 Trainee of the Year Award recipients: Jianqing Liang (JASN), Azuma Nanamatsu (CJASN), and T. Corina Margain (Kidney360)! The award recognizes the best article submitted to each journal by a trainee as the first author.
October 22, 2026 at 7:32 PM